Latinos with obsessive-compulsive disorder: Mental healthcare utilization and inclusion in clinical trials

Journal of Obsessive-Compulsive and Related Disorders

Volumn 1, Issue 2, 2012, Pages 85-97

  Wetterneck, Chad T ^a,d   Little, Tannah E ^a   Rinehart, Kimberly L ^a   Cervantes, Maritza E ^a   Hyde, Emma ^c   Williams, Monnica ^b  

^a UNIVERSITY OF HOUSTON CLEAR LAKE   (United States)

^b UNIVERSITY OF LOUISVILLE   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d NONE   (United States)

Author keywords

Clinical trials; Help seeking; Hispanic; Latino; Obsessive compulsive disorder; Recruitment

Indexed keywords

CANADA; CENTRAL AMERICA; CLINICAL RESEARCH; COGNITIVE THERAPY; ETHNICITY; EVIDENCE BASED PRACTICE; EXPOSURE AND RESPONSE PREVENTION; HEALTH CARE UTILIZATION; HISPANIC; HUMAN; MENTAL HEALTH; MENTAL HEALTH CARE; MEXICO; OBSESSIVE COMPULSIVE DISORDER; OUTCOME ASSESSMENT; PSYCHIATRIC TREATMENT; RELAXATION TRAINING; REVIEW; SYSTEMATIC REVIEW; UNITED STATES; WESTERN HEMISPHERE;

EID: 84861144328     PISSN: 22113649     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jocrd.2011.12.001     Document Type: Review

References (106)

1. Aboujaoude E., Barry J.J., Gamel N. Memantine augmentation in treatment-resistant obsessive-compulsive disorder: An open-label trial. Journal of Clinical Psychopharmacology 2009, 29(1):51-55.
2. Abramowitz J.S. In review: The psychological treatment of obsessive-compulsive disorder. The Canadian Journal of Psychiatry 2006, 51(7):407-416.
3. Abramowitz J.S., Foa E.B., Franklin M.E. Exposure and ritual prevention for obsessive-compulsive disorder: Effects of intensive versus twice-weekly sessions. Journal of Consulting and Clinical Psychology 2003, 71(2):394-398.
4. Abramowitz J.S., Franklin M.E., Schwartz S.A., Furr J.M. Symptom presentation and outcome of cognitive-behavioral therapy for obsessive-compulsive disorder. Journal of Consulting and Clinical Psychology 2003, 71(6):1049-1057.
5. Alegria M., Canino G., Rios R., Vera M., Calderon J., Rusch D., et al. Inequalities in use of specialty mental health services among Latinos, African Americans, and non-Latino whites. Psychiatric Services 2002, 53:1547-1555.
6. Alegria M., Mulvaney-Day N., Woo M., Torres M., Gao S., Oddo V. Correlates of past year mental health service use among Latinos: Results from the national Latino and Asian American study. American Journal of Public Health 2007, 97(1):76-83.
7. American Psychiatric Association Diagnostic and statistical manual of mental disorders 2000, American Psychiatric Association, Washington, DC. 4th ed., text revision.
8. Anger-Diaz B., Schlanger K., Ricon C., Mendoza A.B. Problem solving across cultures: Our Latino experience. Journal of Systematic Therapies 2004, 23:11-27.
9. Asbahr F.R., Castillo A.R., Ito L.M., Latorre M., Moreira M.N., Lotufo-Neto F. Group cognitive-behavioral therapy versus sertraline for the treatment of children and adolescents with obsessive-compulsive disorder. Journal of the American Academy of Child and Adolescent Psychiatry 2005, 44:1128-1136.
10. Benazon N.R., Ager J., Rosenberg D.R. Cognitive behavior therapy in treatment-naïve children and adolescents with obsessive-compulsive disorder: An open trial. Behaviour Research and Therapy 2002, 40:529-539.
11. Bergeron R., Ravindran A.V., Chaput Y., Goldner E., Swinson R., van Ameringen M.A., et al. Setraline and Fluoxetine treatment of obsessive-compulsive disorder: Results of a double-blind, sixth month treatment study. Journal of Clinical Psychopharmacology 2002, 22:148-154.
12. Bernal G., Bonilla J., Padilla-Cotto L., Perez-Prado E.M. Factors associated to outcome in psychotherapy: An effectiveness study in Puerto Rico. Journal of Clinical Psychology 1998, 54:329-342.
13. Bernal G., Jimenez-Chafey M.I., Rodriguez M.M.D. Cultural adaptation of treatments: A resource for considering culture in evidence-based practice. Professional Psychology: Research and Practice 2009, 40:361-368.
14. Bjorgvinsson T., Wetterneck C.T., Powell D.M., Chasson G.S., Webb S.A., Hart J., et al. Treatment outcome for adolescent obsessive-compulsive disorder in a specialized hospital setting. Journal of Psychiatric Practice 2008, 14(3):137-146.
15. Braga D.T., Cordioli A.V., Niederauer K., Manfro G.G. Cognitive-behavioral group therapy for obsessive-compulsive disorder: A 1-year follow-up. Acta Psychiatrica Scandinavica 2005, 112:1-7.
16. Brown R.A., Abrantes A.M., Strong D.R., Mancebo M.C., Menard J., Rasmussen S.A., et al. A pilot study of moderate-intensity aerobic exercise for obsessive compulsive disorder. The Journal of Nervous and Mental Disease 2007, 195(6):514-521.
17. Cabassa L. Latino immigrant mens' perceptions of depression and attitudes toward help seeking. Hispanic Journal of Behavioral Sciences 2007, 29:492-509.
18. Canino G.L., Bird H.R., Shrout P.E., Rubio-Stipec M., Bravo M., Martinez R., et al. The prevalence of specific psychiatric disorders in Puerto Rico. Archives of General Psychiatry 1987, 44:727-735.
19. Caraveo-Anduaga J.J., Bermudez E.D. The epidemiology of obsessive-compulsive disorder in Mexico City. Salud Mental 2004, 27:1-6.
20. Chavira D.A., Garrido H., Bagnarello M., Azzam A., Reus V.I., Mathews C.A. A comparative study of obsessive-compulsive disorder in Costa Rica and the United States. Depression and Anxiety 2008, 25:609-619.
21. Chen J., Vargas-Bustamante A. Estimating the effects of immigration status on mental health care utilizations in the United States. Journal of Immigrant Minority Health 2011, 13:671-680.
22. Cordioli A.V., Heldt E., Bochi D.B., Margis R., de Sousa M.B., Tonello J.F., et al. Cognitive-behavioral group therapy in obsessive-compulsive disorder: A randomized clinical trial. Psychotherapy and Psychometrics 2003, 72:211-216.
23. DeVeaugh-Geiss J., Moroz G., Biederman J., Cantwell D., Fontaine R., Greist J.H., et al. Clomipramine Hydrochloride in childhood and adolescent obsessive-compulsive disorder-A multicenter trial. Journal of the American Academy of Child and Adolescent Psychiatry 1992, 31:45-49.
24. Diefenbach G.J., Abramowitz J.S., Norberg M.M., Tolin D.F. Changes in quality of life following cognitive-behavioral therapy for obsessive-compulsive disorder. Behaviour Research and Therapy 2007, 45:3060-3068.
25. Ennis, S. R., Rios-Vargas, M., & Albert, N. G. (2010). The Hispanic population: 2010. 2010 Census briefs. The United States Census Bureau, US Department of Commerce Economics and Statistics Administration. Retrieved from: http://www.census.gov/prod/cen2010/briefs/c2010br-04.pdf.
26. Fals-Stewart W., Marks A.P., Schafer J. A comparison of behavioral group therapy and individual behavior therapy in treating obsessive-compulsive disorder. Journal of Nervous and Mental Disease 1993, 181:189-193.
27. Foa E.B., Liebowitz M.R., Kozak M.J., Davies S., Campeas R., Franklin M.E., et al. Randomized, placebo controlled trial of exposure and ritual prevention, clomipramine, and their combination in the treatment of obsessive-compulsive disorder. American Journal of Psychiatry 2005, 162:151-161.
28. Fontenelle L.F., Mendlowicz M.V., Marques C., Versiani M. Trans-cultural aspects of obsessive-compulsive disorder: A description of a Brazilian sample and a systematic review of international clinical studies. Journal of Psychiatric Research 2004, 38:403-411.
29. Franklin M.E., Abramowitz J.S., Kozak M.J., Levitt J.T., Foa E.B. Effectiveness of exposure and ritual prevention for obsessive-compulsive disorder: Randomized compared with non-randomized samples. Journal of Consulting and Clinical Psychology 2000, 68(4):594-602.
30. Franklin M.E., Kozak M.J., Cashman L.A., Coles M.E., Rheingold A.A., Foa E.B. Cognitive behavioral treatment of pediatric obsessive-compulsive disorder: An open clinical trial. Journal of the American Academy of Child and Adolescent Psychiatry 1998, 37:412-419.
31. Freeman J.B., Garcia A.M., Coyne L., Ale C., Przeworski A., Himle M., et al. Early childhood OCD: Preliminary findings from a family-based cognitive behavioral approach. Journal of the American Academy of Child and Adolescent Psychiatry 2008, 47:593-602.
32. Freeston M.H., Ladouceur R., Gagnon F., Thibodeau N., Rheaume J., Letarte H., et al. Cognitive-behavioral treatment of obsessive thoughts: A controlled study. Journal of Consulting and Clinical Psychology 1997, 65:405-413.
33. Friedman S., Smith L.C., Halpern B., Levine C., Paradis C., Viswanathan R., et al. Obsessive-compulsive disorder in a multi-ethnic urban outpatient clinic: Initial presentation and treatment outcome with exposure and ritual prevention. Behavior Therapy 2003, 34:397-410.
34. Garnaat S.L., Norton P.J. Factor structure and measurement invariance of the Yale-Brown Obsessive Compulsive Scale across four racial/ethnic groups. Journal of Anxiety Disorders 2010, 24:723-728.
35. Geller D.A., Hoog S.L., Heiligenstein J.H., Ricardi R.A., Tamura R., Kluszynski S., et al. Fluoxetine treatment for obsessive-compulsive disorder in children and adolescents: A placebo-controlled clinical trial. Journal of the American Academy of Child and Adolescent Psychiatry 2001, 40:773-779.
36. Geller D.A., Wagner K.D., Emslie G., Murphy T., Carpenter D.J., Whetherhold E., et al. Paroxetine treatment in children and adolescents with obsessive-compulsive disorder: A randomized, multicenter, double-blind, placebo-controlled trial. Journal of the American Academy of Child and Adolescent Psychiatry 2004, 43:1387-1396.
37. Goodwin R., Koenen K.C., Hellman F., Guardino M., Struening E. Helpseeking and access to mental health treatment for obsessive-compulsive disorder. Acta Psychiatrica Scandinavica 2002, 106(2):143-149.
38. Grant P., Lougee L., Hirschtritt M., Swedo S.E. An open label trial of riluzole, a glutamate antagonist, in children with treatment resistant obsessive-compulsive disorder. Journal of Child and Adolescent Psychopharmacology 2007, 17:761-767.
39. Greist J.H., Chouinard G., DuBoff E., Halaris A., Kim S.W., Koran L., et al. Double-blind parallel comparison of three dosages of sertraline and placebo in outpatients with obsessive-compulsive disorder. Archives of General Psychiatry 1995, 52:289-295.
40. Greist J.H., Marks I.M., Baer L., Kobak K.A., Wenzel K.W., Hirsch M.J., et al. Behavior therapy for obsessive-compulsive disorder guided by a computer or by a clinician compared with relaxation as a control. Journal of Clinical Psychiatry 2002, 63:138-145.
41. Guarnaccia P.J., Martinez I., Arcosta H. Mental health in the Hispanic immigrant community: An overview. Journal of Immigrant and Refugee Services 2005, 3:21-46.
42. Himle J.A., Fischer D.J., Van Etten M.L., Janeck A.S., Hanna G.L. Group behavioral therapy for adolescents with tic-related and non-tic-related obsessive-compulsive disorder. Depression and Anxiety 2003, 17:73-77.
43. Hoehn-Saric R., Ninan P., Black D.W., Stahl S., Greist J.H., Lydiard B., et al. Multicenter double-blind comparison of sertraline and desipramine for concurrent obsessive-compulsive and major depressive disorders. Archives of General Psychiatry 2000, 57:76-82.
44. Horcajadas F., Soto J., Garcia-Cantalapiedra M., Calvin J., Morales J., Salgado M. Effectiveness and tolerability of addition of risperidone in obsessive-compulsive disorder with poor response to serotonin reuptake inhibitors. Actas Españolas de Psiquiatría 2006, 34(3):147-152.
45. Humes, K. R., Jones, N. A., & Ramirez, R. R. (2011). Overview of race and Hispanic origin: 2010. U.S. Census Bureau, 2010 Census Briefs, C2010BR-02 (pp. 1-24).
46. Karno M., Golding J.M., Burnam M.A., Hough R.L., Escobar J., Wells K.M., et al. Anxiety disorders among Mexican Americans and non-Hispanic whites in Los Angeles. The Journal of Nervous and Mental Disease 1989, 177:202-209.
47. Katz R.V., Kegeles S.S., Kressin N.R., Green B.L., Wang Q.M., James S.A., et al. The tuskegee legacy project: Willingness of minorities to participate in biomedical research. Journal of Health Care for the Poor and Underserved 2006, 17:698-715.
48. Kearney L., Draper M., Baron A. Counseling utilization by ethnic minority college students. Cultural Diversity and Ethnic Minority Psychology 2005, 11(3):272-285.
49. Kessler R., Berglund P., Demler O., Jin R., Merikangas K., Walters E. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the national comorbidity survey replication. Archives of General Psychiatry 2005, 62(6):593-602. 10.1001/archpsyc.62.6.593.
50. Kim S.W., Dyksen M.W., Pheley A.M., Hoover K.M. The Yale-Brown Obsessive-Compulsive Scale: Measures of internal consistency. Psychiatry Research 1994, 51:203-211.
51. Koran L.M., McElroy S.L., Johnathan D., Rasmussen S.A., Hollander E., Jenike M.A. Fluvoxamine versus clomipramine for obsessive-compulsive disorder: A double-blind comparison. Journal of Clinical Psychopharmacology 1996, 16:121-129.
52. Kronig M.H., Apter J., Asnis G., Bystritsky A., Curtis G., Ferguson J., et al. Placebo-controlled, multicenter study of sertraline treatment for obsessive-compulsive disorder. Journal of Clinical Psychopharmacology 1999, 19:172-176.
53. Lam J.N., Steketee G.S. Reducing obsessions and compulsions through behavior therapy. Psychoanalytic Inquiry 2001, 21:157-182.
54. Liebowitz M.R., Turner S.M., Piacentini J., Beidei D.C., Clarvit S.R., Simpson H.B. Fluoxetine in children and adolescents with OCD: A placebo-controlled trial. Journal of the American Academy of Child and Adolescent Psychiatry 2002, 41:1431-1438.
55. Malgady R.G., Costantino G. Symptom severity in bilingual Hispanics as a function of children ethnicity and language of interview. Psychological Association 1998, 10:120-127.
56. March J.S., Mulle K., Herbel B. Behavioral psychotherapy for children and adolescents with obsessive-compulsive disorder: An open trial of a new protocol-driven treatment package. Journal of the American Academy of Child and Adolescent Psychiatry 1994, 33:333-341.
57. McLean P.D., Whittal M.L., Thordarson D.S., Taylor S., Sochting I., Koch W.J., et al. Cognitive versus behavior therapy in the group treatment of obsessive-compulsive disorder. Journal of Consulting and Clinical Psychology 2001, 69(2):205-214.
58. Mehta M. A comparative study of family-based and patient-based behavioural management in obsessive-compulsive disorder. British Journal of Psychiatry 1990, 157:133-135.
59. Meyer E., Shavitt R.G., Leukkefeld C., Heldt E., Souza F.P., Knapp P., et al. Adding motivational interviewing and thought-mapping to cognitive-behavioral group therapy: Results from a randomized clinical trial. Revista Brasileira de Psiquiatria 2010, 32:20-29.
60. Murphy T.K., Mutch J., Reid J.M., Edge P.J., Storch E.A., Bengtson M., et al. Open label aripiprazole in the treatment of youth with tic disorders. Journal of Child and Adolescent Psychopharmacology 2009, 19:441-447.
61. Nadeem E., Lange J., Edge D., Fongwa M., Belin T., Miranda J. Does stigma keep poor young immigrant and U.S. born black and Latina women from seeking mental health care?. Psyhiatric Services 2007, 58(12):1547-1554.
62. NICE. (2006) Obsessive-compulsive disorder: Core interventions in the treatment of obsessive-compulsive disorder and body dysmorphic disorder. The British Psychological Society & The Royal College of Psychiatrists. http://www.nice.org.uk.
63. Nicolini H., Orozco B., Giuffra L., Paez F., Mejia J., de Carmona M.S., et al. Age of onset, gender and severity in obsessive-compulsive disorder. A study on a Mexican population. Salud Mental 1997, 20:1-4.
64. Olsen T., Vera B., Perez O. Preliminary study of OCD and health disparities at the U.S.-Mexico border. Hispanic Health Care International 2003, 4:89-99.
65. Organista K.C., Munoz R.F. Cognitive behavioral therapy with Latinos. Cognitive and Behavioral Practice 1996, 3:255-270.
66. Orozco B., de la Fluente J.R., Nicolini H. Bases bioquímicas y tratamiento farmacológico del trastorno obsesivo compulsivo: experiencia del IMP en 70 pacientes. Salud Mental 1995, 18:1-13.
67. Paris M., Anez L., Bedregal L., Andres-Hyman R., Davidson L. Help seeking and satisfaction among Latinas: The roles of setting, ethnic identity, and therapeutic alliance. Journal of Community Psychology 2005, 33(3):299-312.
68. Petribu K., Bastos O. Comorbidade em transtorno obsessivo-compulsivo aparte: objetivos, metodologia, resultados e discussäo. Jornal Brasileiro de Psiquiatria 1997, 46:417-425.
69. Raffin A.L., Fachel J.M.G., Ferrão, de Souza F.P., Cordioli A.V. Predictors of response to group cognitive-behavioral therapy in the treatment of obsessive-compulsive disorder. European Psychiatry 2008, 24(5):277-306.
70. Rector N.A., Cassin S.E., Richter M.A. Psychological treatment of obsessive-compulsive disorder in patients with major depression: A pilot randomized control trial. Canadian Journal of Psychiatry 2009, 54(12):846-851.
71. Redmond M., Galea S., Delva J. Examining racial/ethnic minority treatment experiences with specialty behavioral health service providers. Community Mental Health Journal 2009, 45:85-96.
72. Riddle M.A., Reeve E.A., Yaryura-Tobias J.A., Yang H.M., Claghorn J.L., Gaffney G., et al. Fluvoxamine for children and adolescents with obsessive-compulsive disorder: A randomized, controlled, multicenter trial. Journal of the American Academy of Child and Adolescent Psychiatry 2001, 40(2):222-230.
73. Riddle M.A., Schahill L., King R.A., Hardin M.T., Anderson G.M., Ort S.I., et al. Double-blind, crossover trial of fluoxetine and placebo in children and adolescents with obsessive-compulsive disorder. Journal of American Academy of Child and Adolescent Psychiatry 1992, 31(6):1062-1070.
74. Romano S., Goodman W., Tamura R., Gonzales J., The Collaborative Research Group Long-term treatment of obsessive-compulsive disorder after an acute response: A comparison of fluoxetine versus placebo. Journal of Canadian Psychopharmacology 2001, 21(1):46-54.
75. Rosenberg D.R., Stewart C.M., Fitzgerald K.D., Tawile V., Carroll E. Paroxetine open-label treatment of pediatric outpatients with obsessive-compulsive disorder. Journal of American Academy of Child and Adolescent Psychiatry 1999, 38:1180-1185.
76. Ruscio A.M., Stein D.J., Chiu W.T., Kessler R.C. The epidemiology of obsessive-compulsive disorder in the National Comorbidity Survey Replication. Molecular Psychiatry 2010, 15(1):53-63.
77. Santisteban D.A., Perez-Vidal A., Coatsworth J.D., Kurtines W.M., Schwartz S.J., LaPerriere A., et al. Efficacy of brief strategic family therapy in modifying Hispanic adolescent behavior problems and substance use. Journal of Family Psychology 2003, 17:121-133.
78. Shattell M.M., Hamilton D., Starr S.S., Jenkins C.J., Hinderliter N.A. Mental health service needs of a Latino population: A community-based participatory research project. Issues in Mental Health Nursing 2008, 29:351-370.
79. Simpson H.B., Foa E.B., Liebowitz M.R., Ledley D.R., Huppert J.D., Cahill S., et al. A randomized, controlled trial of cognitive-behavioral therapy for augmenting pharmacotherapy in obsessive-compulsive disorder. The American Journal of Psychiatry 2008, 165:621-630.
80. Simpson H.B., Franklin M., Foa E.B., Campeas R., Liebowitz M.R., Han C.G., et al. A randomized, controlled trial of cognitive-behavioral therapy for augmenting pharmacotherapy in obsessive-compulsive disorder. American Journal of Psychiatry 2008, 165:621-650.
81. Snowden L., Cheung F. Use of inpatient mental health services by members of ethnic minority groups. American Psychologist 1990, 45(3):347-355.
82. Sousa M.B., Isolan L.R., Oliveira R.R., Manfro G.G., Cordioli A.V. A randomized clinical trial of cognitive-behavioral group therapy and sertraline in the treatment of obsessive-compulsive disorder. Journal of Clinical Psychiatry 2006, 67:1133-1139.
83. Storch E.A., Geffken G.R., Merlo L.J., Mann G., Duke D., Munson M., et al. Family based cognitive-behavioral therapy for pediatric obsessive-compulsive disorder: Comparison of intensive and weekly approaches. Journal of American Academy of Child and Adolescent Psychiatry 2007, 46(4):469-478.
84. Storch E.A., Merlo L.J., Bengtson M., Murphy T.K., Lewis M.H., Yang M.C., et al. D-cycloserine does not enhance exposure-response prevention therapy in obsessive-compulsive disorder. International Clinical Psychopharmacology 2007, 22:230-237.
85. Storch E.A., Murphy T.K., Geffken G.R., Mann G., Adkins J., Merlo L.J., et al. Cognitive-behavioral therapy for PANDAS-related obsessive-compulsive disorder: Findings from a preliminary waitlist controlled open trial. Journal of American Academy of Child and Adolescent Psychiatry 2006, 45:1171-1178.
86. Storch E.A., Murphy T.K., Goodman W.K., Geffken G.R., Lewin A.B., Henin A., et al. A preliminary study of D-cycloserine augmentation of cognitive behavioral therapy in pediatric obsessive-compulsive disorder. Biological Psychiatry 2010, 68:1073-1076.
87. Sue S., Fujino D., Hu L., Takeuchi D., Zane N. Community mental health services for ethnic minority groups: A test of the cultural responsiveness hypotheses. Journal of Consulting and Clinical Psychology 1991, 59(4):533-540.
88. Sussman N. Obsessive-compulsive disorder: A commonly missed diagnosis in primary care. Primary Psychiatry 2003, 10(12):14.
89. Taylor S., Thordarson D.S., Spring T., Yeh A.H., Corcoran K.M., Eugster K., et al. Telephone-administered cognitive behavior therapy for obsessive-compulsive disorder. Cognitive Behavior Therapy 2003, 32:13-25.
90. Tolin D.F., Maltby N., Diefenbach G.J., Hannan S.E., Worhunsky P. Cognitive-behavioral therapy for medication nonresponders with obsessive-compulsive disorder: A wait-list-Controlled open trial. Journal of Clinical Psychiatry 2004, 65:922-931.
91. Twohig M.P., Hayes S.C., Plumb J.C., Pruitt L.D., Collins A.B., Hazlett-Stevens H., et al. A randomized clinical trial of acceptance and commitment therapy versus progressive relaxation training for obsessive-compulsive disorder. Journal of Consulting and Clinical Psychology 2010, 78:705-716.
92. Ulloa R.E., Nicolini H., Avila M., Fernandez-Guasti A. Age onset subtypes of obsessive compulsive disorder: Differences in clinical response to treatment with clomipramine. Journal of Child and Adolescent Psychopharmacology 2007, 17(1):85-96.
93. United States Census Bureau.(2010). Summary File 1. U.S. Department of Commerce, Washington, DC, US.
94. U.S. Department of Health and Human Services, Public Health Service. (2002). National Institutes of Health: outreach notebook for the NIH guidelines on inclusion of women and minorities as subjects in clinical research. NIH Publication no. 03-7036. National Institutes of Health, Bethesda, MD.
95. U.S. Department of Health and Human Services, National Institute of Mental Health (2008). Numbers count: Mental disorders in America. Retrieved from: http://www.nimh.nih.gov/health/publications/the-numbers-count-mental-disorders-in-america/index.shtml.
96. Vega W., Karno M., Alegria M., Alvidrez J., Bernal G., Escamilla M., et al. Research issues for improving treatment of U.S. Hispanics with persistent mental disorders. Psychiatric Services 2007, 58(3):385-394.
97. Vega W.A., Kolody B., Aguilar-Gaxiola S., Alderate E., Catalano R., Carveo-Anduaga J. Lifetime prevalence of DSM-III-R psychiatric disorders among urban and rural Mexican Americans in California. Archives of General Psychiatry 1998, 55:771-778.
98. Vega W., Kolody B., Aguilar-Gaxiola S. Help seeking for mental health problems among Mexican Americans. Journal of Immigrant Health 2001, 3(3):133-140.
99. Vega W.A., Lopez S.R. Priority issues in Latino mental health services research. Mental Health Services Research 2001, 3:189-200.
100. Vicente B., Kohn R., Rioseco P., Saldivia S., Levav I., Torres S. Lifetime and 12-month prevalence of DSM-III-R disorders in the Chile psychiatric prevalence study. The American Journal of Psychiatry 2006, 163:1362-1370.
101. Weissman M.M., Bland R.C., Canino G.J., Greenwald S., Hwu H., Lee C., et al. The cross national epidemiology of obsessive compulsive disorder. Journal of Clinical Psychiatry 1994, 55:5-10.
102. Washington C.S., Norton P.J., Temple S. Obsessive-compulsive symptoms and Obsessive-Compulsive Disorder: A multi-racial/ethnic analysis of a student population. The Journal of Nervous and Mental Disorders 2008, 196:456-461.
103. Whittal M.L., Thordarson D.S., McLean P.D. Treatment of obsessive-compulsive disorder: Cognitive-behavior therapy vs. exposure and response prevention. Behaviour Research and Therapy 2005, 43:1559-1576.
104. Whittal M.L., Woody S.R., McLean P.D., Rachman S.J., Robichaud M. Treatment of obsessions: A randomized controlled trial. Behaviour Research and Therapy 2010, 48:295-303.
105. Williams M., Powers M., Yun Y., Foa E. Minority participation in randomized controlled trials for obsessive-compulsive disorder. Journal of Anxiety Disorders 2010, 24:171-177.
106. Williams M.T., Turkheimer E., Schmidt K.M., Oltmanns T.F. Ethnic identification biases responses to the Padua Inventory for Obsessive-Compulsive Disorder. Assessment 2005, 12:174-185.